MED SAFETY& THEORY info Flashcards

1
Q
  1. what are some inherent weaknesses
  2. what are some safeguards
A
  1. what are some inherent weaknesses
    distraction, human error and look alike sound alike medications
  2. what are some safeguards
    IV Safety software, policies and health practitioner training
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

7 rights

A

What are the 7 rights of medication administration?
patient, time, drug, dose, documentation, route, reason/refusal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

medication pathway in prescribing, name the various stages

A

how many factors involved in prescribing medication
5. evaluate patient. establish need for medication. select medication. individualise medication. prescribe medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does APINCHS stand for

A

high risk medications and systems:
A - Antimicrobials
P - Potassium
I - Insulin
N - Narcotics
C - Chemotherapy
H - Heparin and anticoagulants
S - Systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

defined pharmacokinetics and pharmacodynamics

A

What is pharmacodynamics?
The study of what the drug does to the body

What is pharmacokinetics?
what the body does to the drug
(ADME)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe absorption

A

the way in which a drug is absorbed from pharmaceutical formulation into the bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what influences absorption

A

route of administration, nausea, vomiting, food, other medications and stomach acidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe distribution
and what influences it

A

how the drug is distributed to its target

perfusion of body tissue and whether a drug is hydrophilic or lipophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe metabolism
describe first metabolism

A

describe metabolism:
it is a protective mechanism that excretes toxins from the body. liver is the main organ involved. uses enzymes (CYP) and converts fat soluble drugs to water soluble

describe first metabolism:
drug enters portal circulation to the liver before systemic circulation and results in reduced bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe excretion

A

removal of a drug from the body, either metabolite or unchanged drug. kidney and liver are main organs involved. kidney climates water soluble drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is therapeutic drug monitoring TDM
and principles of TDM
drugs suitable for TDM

A

**what is therapeutic drug monitoring (TDM)
The testing of drug levels in the bloodstream at specific intervals.

principles of TDM
dosage, dosing interval, patient characteristics, sample type and timing of sample collection

drugs suitable for TDM
antimicrobials, anti epileptic agents, cardiovascular agents, anticoags, psychotic agents and respiratory agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is a clinical trial &
explain the two types of clinical trials

A

research studies that test a medical, surgical, or behavioral intervention in people

explain the two types of clinical trials
randomised controlled studyis a scientific experiment used to control factors not under direct experimental control. A case controlled study is a type of observational study in which two existing groups differing in outcome are identified and compared.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

explain phase 1-4 of a clinical trial

A

phase 1 of a CT
test new biomedical intervention for the first time in a small group to evaluate safety

phase 2 of a CT
study the intervention in a larger group of people to determine efficiency and further evaluate safety

phase 3 of a CT
study the efficacy in larger groups by comparing the intervention to other interventions/studies. Monitor adverse effects and collect information

phase 4 of a CT
after the intervention has been marketed. Monitor the effectiveness in the general population and monitor adverse effects over longer periods of time. Monitor potential use of intervention for other diseases/conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what BP is considered hypertensive

A

140/90 upwards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADME: Absorption (what effects it)

A
  • the movement of the drug from the administrative site into the blood
  • Food, Some medication, Acidity of the stomach, A Patient w nausea and vomiting, Route of administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADME: Distribution (What effects it)

ADME: Distribution (What effects it)

A

The movement of the drug through the body.
- Hydrophilic or lipophilic
- Perfusion of body tissues

17
Q

Hydrophilic vs. lipophilic

A

Hydrophilic-water soluble,
Lipophilic-aka hydrophobic

18
Q

What is evidence based medicine -

A

Systematic approach that considers the best and most reliable research about medical treatment
Combines with clinical experience and knowledge
Considers the needs of patients

19
Q

Different phases in a clinical trial

A
  1. Done in a small group to evaluate safety
  2. Done on a larger group (hundreds) to determine efficacy to further evaluate safety
  3. Increase to thousands
  4. After an intervention has been marketed
20
Q

MIMS strengths and weaknesses

A

Benefits of MiMS - current regulatory status, some pharmacokinetic and pharmacodynamic data, comprehensive info on side effects
Limitations of MiMS - can be out of date

21
Q
A